The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect

  • Yousef Rasmi
  • , Ladan Jalali
  • , Saliha Khalid
  • , Ameneh Shokati
  • , Poonam Tyagi
  • , Alpaslan Ozturk
  • , Amir Nasimfar

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Abstract

Prolactin (PRL) is an endocrine hormone secreted by the anterior pituitary gland that has a variety of physiological effects, including milk production, immune system regulation, and anti-inflammatory effects. Elevated levels of PRL have been found in several viral infections, including 2019 coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), a viral pathogen that has recently spread worldwide. PRL production is increased in SARS-CoV2 infection. While PRL can trigger the production of proinflammatory cytokines, it also has several anti-inflammatory effects that can reduce hyperinflammation. The exact mechanism of PRL's contribution to the severity of COVID-19 is unknown. The purpose of this review is to discuss the interaction between PRL and SARS-CoV2 infection and its possible association with the severity of COVID-19.

Original languageEnglish
Article number156253
JournalCytokine
Volume169
DOIs
StatePublished - Sep 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • Immunomodulatory effects
  • Prolactin
  • SARS-CoV-2
  • Severity

Fingerprint

Dive into the research topics of 'The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect'. Together they form a unique fingerprint.

Cite this